The importance of BCAT1 as a therapeutic target is highlighted by the discovery of a small-molecule BCAT1 inhibitor, eupalinolide B (EB), which induced apoptosis in TNBC cells and showed anti-tumor effects in preclinical models [36]. The gene discussed is BCAT1; the disease is neoplasm.